Hyaluronic acid (HA) is a natural polysaccharide with excellent moisturizing, lubricating and regenerative properties, widely used in cosmetics (dermal fillers, facial creams), pharmaceuticals (joint treatments, wound healing) and nutrition (dietary supplements). The global HA market shows constant growth, driven by the demand for anti-aging products, minimally invasive therapies and regenerative solutions in medicine. This trend, coupled with the growing preference for safe and biocompatible ingredients, positions HA as a key component in various sectors.
Our proposal is based on a controlled liquid fermentation process using the bacteria Streptococcus equi subsp. zooepidemicus, recognized in the industry for its ability to generate high-quality hyaluronic acid.
Phase I: R&D (Research and Development)
Fermentation parameter studies (pH, temperature, substrates).
Purity testing and HA characterization to meet international standards.
Phase II: Pilot and Certifications
Scaling up to a medium-capacity pilot plant.
Implementation of quality regulations (GMP, ISO) and health registration with national and international regulatory bodies.
Phase III: Industrial Production and Commercialization
Increased production capacity and cost optimization.
Partnerships with global distributors and cosmetic/pharmaceutical laboratories.
Brand consolidation and expansion into high-value markets (USA, Europe, and Asia).
We are seeking visionary investors, particularly in Europe and the United States, who are eager to join a project with a strong scientific foundation, international reach, and significant impact on the global market. By joining this initiative, you will benefit from:
Get in touch with us
to learn more about our business plan, financial projections, and roadmap to establish leadership in the production of high-quality hyaluronic acid. Together, we can make a difference in one of the most promising sectors in the health and wellness industry!